Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Onconova Therapeutics (ONTX)
NASDAQ:ONTX
Onconova Therapeutics (ONTX) Stock Price & Analysis
1,745 Followers
ONTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.62 - $1.49
Previous Close$0.79
Volume12.53K
Average Volume (3M)55.67K
Market Cap
$16.47M
Enterprise ValueN/A
Total Cash (Recent Filing)$29.73M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.8
Beta1.51
Next Earnings
Nov 15, 2023EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.99
Shares Outstanding20,977,625
10 Day Avg. Volume40,143
30 Day Avg. Volume55,672
Standard Deviation0.38
R-Squared0.06
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.90
Price to Sales (P/S)288.90
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$9.00Price Target Upside1046.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Onconova Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ONTX FAQ
What was Onconova Therapeutics’s price range in the past 12 months?
Onconova Therapeutics lowest stock price was $0.62 and its highest was $1.49 in the past 12 months.
What is Onconova Therapeutics’s market cap?
Currently, no data Available
When is Onconova Therapeutics’s upcoming earnings report date?
Onconova Therapeutics’s upcoming earnings report date is Nov 15, 2023 which is in 54 days.
How were Onconova Therapeutics’s earnings last quarter?
Onconova Therapeutics released its earnings results on Aug 10, 2023. The company reported -$0.2 earnings per share for the quarter, beating the consensus estimate of -$0.312 by $0.112.
Is Onconova Therapeutics overvalued?
According to Wall Street analysts Onconova Therapeutics’s price is currently Undervalued.
Does Onconova Therapeutics pay dividends?
Onconova Therapeutics does not currently pay dividends.
What is Onconova Therapeutics’s EPS estimate?
Onconova Therapeutics’s EPS estimate is -$0.29.
How many shares outstanding does Onconova Therapeutics have?
Onconova Therapeutics has 20,977,625 shares outstanding.
What happened to Onconova Therapeutics’s price movement after its last earnings report?
Onconova Therapeutics reported an EPS of -$0.2 in its last earnings report, beating expectations of -$0.312. Following the earnings report the stock price went down -5.882%.
Which hedge fund is a major shareholder of Onconova Therapeutics?
Currently, no hedge funds are holding shares in ONTX
---
Onconova Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (1046.50% Upside)
$9.00 (1046.50% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.2%
Last 30 Days ▼ 3.1%
Last 30 Days ▼ 3.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.78%
12-Months-Change
Fundamentals
Return on Equity
-72.65%
Trailing 12-Months
Asset Growth
-36.62%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Onconova Therapeutics
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
---
Top 5 ETFs holding ONTX
Vanguard Total Stock Market ETF
$287.41K
iShares Core S&P Total U.S. Stock Market ETF
$2.36
Up to five ETFs with an Outperform Smart Score that hold ONTX. The ETFs are listed according to market value of ONTX within the ETF
---